Overview
Peripheral facial palsy (PFP), commonly known as Bell's palsy when idiopathic, encompasses a range of conditions characterized by unilateral weakness or paralysis of the facial muscles innervated by the facial nerve. The etiology of PFP is diverse, including viral reactivation (such as varicella-zoster virus, CMV), bacterial infections (like Lyme disease), autoimmune disorders, and less commonly, neoplastic processes. Understanding the pathophysiology, epidemiology, clinical presentation, and management strategies is crucial for effective patient care. This guideline synthesizes evidence from various studies to provide a comprehensive overview for clinicians managing PFP.
Pathophysiology
The pathophysiology of peripheral facial palsy involves complex interactions between the facial nerve and various pathogens or inflammatory processes. Recent studies have highlighted the role of T cell responses in identifying causative agents, even in the absence of typical clinical manifestations. For instance, increased expression of immune checkpoint molecules like PD-1 and CTLA-4 on T cells can indicate VZV involvement in PFP cases [PMID:37880696]. This suggests that immune dysregulation plays a significant role in the development of PFP, particularly when viral reactivation is suspected.
Neurophysiological changes further elucidate the mechanisms underlying PFP. Sensory motor gate mechanisms and enhanced excitability of brainstem neurons contribute to the clinical presentation, as evidenced by changes in somatosensory evoked responses (SBR) [PMID:19500654]. These neurophysiological alterations underscore the importance of assessing brainstem function in patients with PFP. Additionally, serological evidence points to CMV as a frequent culprit, with reactivation of latent CMV identified in 72% of acute peripheral facial palsy (APFP) cases [PMID:6316479]. This highlights the need for comprehensive serological testing to identify potential infectious triggers.
Epidemiology
Peripheral facial palsy exhibits variability across different demographic groups and seasonal patterns. A retrospective analysis encompassing 405 datasets from 198 patients aged 4 to 90 years revealed significant variability in PFP incidence across age groups, suggesting that both pediatric and geriatric populations are susceptible [PMID:40866588]. Epidemiological data from Korea indicate a substantial clinical burden, with over 111,000 patients seeking treatment at Korean medicine facilities for facial nerve disorders in 2019 [PMID:35801754]. This underscores the public health significance of PFP.
Seasonal trends also influence PFP incidence, with a notable peak during winter months observed in multiple studies. For example, fourteen out of nineteen patients in one study experienced symptom onset during winter, indicating a potential seasonal pattern linked to viral reactivation or environmental factors [PMID:36065885]. Despite extensive research, rickettsial infections have not been implicated in PFP, as evidenced by negative serological tests in a cohort of patients [PMID:36065885]. These findings help clinicians anticipate and monitor seasonal variations in PFP presentations.
Clinical Presentation
The clinical presentation of peripheral facial palsy is multifaceted, encompassing motor deficits and sensory disturbances. The FaCE scale, which evaluates dimensions such as facial movement, comfort, oral function, eye symptoms, lacrimal control, and social function, alongside the FDI scale focusing on physical and social aspects, provides a comprehensive assessment of patient impact [PMID:41107058]. Accurate assessment of facial muscle activity and symmetry is crucial for monitoring recovery and guiding rehabilitation efforts, as highlighted by studies emphasizing the importance of detailed clinical evaluations [PMID:40866588].
Patients typically present with incomplete facial movement, often accompanied by symptoms like postauricular pain, altered tear production (lacrimation), taste disturbances, and hyperacusis, which tend to peak within the first week post-onset [PMID:35801754]. The Synkinesis Assessment Questionnaire (SAQ) and Sunnybrook Facial Grading System (SFGS) have shown strong correlations between subjective patient experiences and objective clinical assessments, particularly during facial movements like smiling and lip protrusion [PMID:35842351]. Preceding myalgia is another notable symptom, significantly more prevalent in PFP patients compared to controls [PMID:36065885]. Additionally, activity limitations correlate with the severity and etiology of PFP, though psychological distress does not directly correlate with neurological impairment, indicating a nuanced impact on patient quality of life [PMID:32935953].
Diagnosis
Diagnosing peripheral facial palsy involves a combination of clinical assessment and ancillary investigations to rule out central causes and identify potential infectious triggers. Traditional scales focusing on motor function are complemented by newer tools like the FaCE and FDI scales, which offer a broader evaluation of quality of life and psychosocial impacts [PMID:41107058]. Technological advancements, such as automated facial symmetry analysis using standardized photographs, provide objective measures that enhance diagnostic accuracy and monitoring [PMID:40866588].
Laboratory tests, including serological assays and cerebrospinal fluid (CSF) analysis, play pivotal roles. While blood tests for pathogen-specific nucleic acids and antibodies offer less invasive diagnostic options, their specificity and narrow diagnostic windows limit their utility [PMID:37880696]. CSF analysis, however, remains valuable for detecting pleocytosis, pathogenic nucleic acids, and intrathecal antibody increases, aiding in diagnosing infectious causes [PMID:37880696]. Electrophysiological evaluations such as electromyography (EMG), electroneurography (ENoG), and the Blink Reflex test are essential for ruling out central nervous system disorders and assessing nerve function, typically performed 2-3 weeks post-onset [PMID:35801754]. Notably, ENoG-MM, with specific electrode placements, demonstrates high sensitivity in predicting synkinesis, making it a valuable tool for early identification of patients at risk [PMID:38552423].
Differential Diagnosis
Differentiating peripheral facial palsy from central causes and other neurological conditions is critical. Non-idiopathic PFP often stems from infectious triggers, with varicella-zoster virus (VZV) and Borrelia burgdorferi being common pathogens, alongside rarer causes like autoimmune diseases and tumors [PMID:37880696]. Studies have ruled out significant roles for rickettsial infections in PFP, as evidenced by negative serological tests for Rickettsia felis and Rickettsia helvetica [PMID:36065885]. Central nervous system disorders must be excluded through thorough clinical evaluation and neuroimaging if indicated. CSF analysis, particularly PCR testing for herpesviruses and Borrelia burgdorferi, helps rule out infectious etiologies beyond VZV and CMV [PMID:36065885].
Management
Effective management of peripheral facial palsy integrates pharmacological interventions, rehabilitation strategies, and multidisciplinary approaches tailored to individual patient needs. In cases where the causative agent remains unclear or diagnosis is delayed, a combination therapy including corticosteroids, antivirals, and antibiotics is often recommended to mitigate prolonged symptoms and prevent nerve damage [PMID:37880696]. Acupuncture and other Korean medicine treatments are widely sought after in certain populations, reflecting a significant clinical demand despite limited Western guideline recommendations [PMID:35801754].
Rehabilitation plays a crucial role, with botulinum toxin type A (BTX-A) injections showing substantial improvements in facial muscle function, quality of life, and reduced synkinesis, as measured by scales like the Sunnybrook Facial Grading System (SFGS) and Facial Clinimetric Evaluation (FaCE) [PMID:37437657]. Neuromuscular retraining combined with BTX-A infiltration further enhances recovery metrics, suggesting a promising approach for long-term outcomes [PMID:37437657]. Multidisciplinary team (MDT) approaches, integrating surgical interventions with functional neuromuscular magnetic resonance imaging (fNMR) techniques, have shown positive impacts on facial symmetry, function, and aesthetics in patients with poor recovery [PMID:38286419].
Complications
Synkinesis, characterized by involuntary muscle contractions during facial movements, is a significant complication affecting a substantial proportion of PFP patients. This phenomenon arises from aberrant regrowth of facial nerve fibers post-axonal damage, significantly impacting quality of life [PMID:36073956]. The severity and persistence of synkinesis often correlate with the duration and severity of the initial palsy, necessitating targeted rehabilitation strategies to mitigate its effects [PMID:35842351].
Prognosis & Follow-up
The prognosis for peripheral facial palsy varies widely, with approximately 30% of patients with Bell’s palsy and higher percentages with other etiologies failing to achieve complete recovery, often resulting in residual muscle weakness or synkinesis [PMID:36073956]. Early prognostic tools like ENoG-MM, with a cut-off of 45% sensitivity for predicting synkinesis, are invaluable for guiding follow-up care and rehabilitation planning [PMID:38552423]. Patient-reported outcome measures, such as the Synkinesis Assessment Questionnaire (SAQ), are essential for evaluating recovery trajectories and adjusting treatment plans accordingly [PMID:35842351]. Over time, activity limitations tend to decrease, reflecting gradual improvement in functional status [PMID:32935953].
Special Populations
Patients undergoing surgical reconstruction for severe PFP require specialized multidisciplinary care due to unique recovery trajectories and potential complications. Gender differences also influence outcomes, with female patients often experiencing more severe psychological distress and participation restrictions compared to males [PMID:32935953]. Tailored rehabilitation strategies that account for these factors are crucial for optimizing recovery and quality of life in these subgroups.
Key Recommendations
These recommendations aim to guide clinicians in providing evidence-based, patient-centered care for peripheral facial palsy, enhancing both short-term recovery and long-term quality of life outcomes.
References
1 Chen M, Wang Y, Gu Z, Guo J, Cui W, Zhao B et al.. Translation, cross-cultural adaptation and psychometric validation of the Chinese version of Facial Clinimetric Evaluation Scale (FaCE) and Facial Disability Index (FDI). BMJ open quality 2025. link 2 Heinrich A, Volk GF, Dobel C, Guntinas-Lichius O. Deep learning-based automatic facial symmetry scoring in peripheral facial palsy. Scientific reports 2025. link 3 Mohammad L, Fousse M, Wenzel G, Flotats Bastardas M, Faßbender K, Dillmann U et al.. Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin. Journal of neuroinflammation 2023. link 4 Franchignoni F, Giordano A, Cecini M, Caspani P, Mandrini S, Dall'angelo A et al.. Translation, cross-cultural adaptation, and validation of the Italian version of the Synkinesis Assessment Questionnaire in individuals with peripheral facial palsy. European journal of physical and rehabilitation medicine 2022. link 5 Lim H, Lee Y, Lee S, Kim YS. Effectiveness and safety of Korean medicine treatment based on the clinical practice guidelines in patients with acute peripheral facial palsy: A protocol for a multicenter, prospective, observational study. Medicine 2022. link 6 Okazaki A, Nakano H, Haginomori SI, Ayani Y, Inaka Y, Ozaki A et al.. Prognostic value of electroneurography using the midline method for predicting the development of synkinesis after peripheral facial palsy. Auris, nasus, larynx 2024. link 7 Kimber R, Rodger A, Higgins R, Christofi G. A Combined Approach of Facial Neuromuscular Rehabilitation and Surgical Reconstruction in the Remediation of Facial Palsy: A Multidisciplinary Team Approach. Facial plastic surgery : FPS 2024. link 8 Díaz-Aristizabal U, Valdés-Vilches M, Fernández-Ferreras TR, Calero-Muñoz E, Bienzobas-Allué E, Aguilera-Ballester L et al.. Effect of botulinum toxin type A in functionality, synkinesis and quality of life in peripheral facial palsy sequelae. Neurologia 2023. link 9 Lannadère E, Picard D, Hervochon R, Tankéré F, Lamas G, Gatignol P. Contribution of the Synkinesis Assessment Questionnaire and the Sunnybrook Facial Grading System to the evaluation of synkinesis after peripheral facial palsy: A STROBE observational study. European annals of otorhinolaryngology, head and neck diseases 2023. link 10 Jensen BB, Al-Mashkur NM, Chen M, Fournier PE, Stenager E. Rickettsial infections are an unlikely cause of peripheral facial palsy in Southern Jutland, Denmark. Danish medical journal 2022. link 11 Pavese C, Cecini M, Caspani P, Monteleone S, Klersy C, Dalla Toffola E. Activity limitations and participation restrictions in patients with peripheral facial palsy: a cross-sectional study over a six-year period. European journal of physical and rehabilitation medicine 2020. link 12 Silva MFF, Peres SV, Lazarini PR, Cunha MC. Evaluation of the sensitivity of the Psychosocial Scale of Facial Appearance in peripheral facial paralysis. CoDAS 2018. link 13 Luijmes RE, Pouwels S, Beurskens CH, Kleiss IJ, Siemann I, Ingels KJ. Quality of life before and after different treatment modalities in peripheral facial palsy: A systematic review. The Laryngoscope 2017. link 14 Uzun N, Adatepe T, Azizli E, Alkan Z, Yiğit Ö, Gündüz A et al.. A novel muscle for electroneurography in peripheral facial palsy: occipitalis. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2016. link 15 Marsk E, Hammarstedt-Nordenvall L, Engström M, Jonsson L, Hultcrantz M. Validation of a Swedish version of the Facial Disability Index (FDI) and the Facial Clinimetric Evaluation (FaCE) scale. Acta oto-laryngologica 2013. link 16 Erkol G, Kiziltan ME, Uluduz D, Uzun N. Somatosensory eye blink reflex in peripheral facial palsy. Neuroscience letters 2009. link 17 Traavik T, Størvold G, Sundsfjord A, Lund S, Mair IW. Peripheral facial palsy and coincidental cytomegalovirus infection or reactivation. Scandinavian journal of infectious diseases 1983. link